Keyword: R&D

News

Metabolix Sells Biopolymer Assets to CJ CheilJedang

25.08.2016 - Just one month after announcing it was quitting the biopolymers business, Metabolix has signed a binding letter of intent (LOI) to sell its assets to South Korean food company CJ...

News

Croda and Synthomer Eyeing Deals?

25.08.2016 - UK specialty chemicals players Croda and Synthomer are eyeing bolt-on acquisitions as well as larger transformational deals, the chief executives of the two companies have told the...

News

Casebia Moves Research to New Massachusetts Facility

22.08.2016 - Casebia Therapeutics, a joint venture between Bayer and CRISPR Therapeutics, has hired new laboratory and office space in Cambridge, Massachusetts, USA, for its primary research...

News

Frutarom Enters Irish Market with Redbrook Buy

19.08.2016 - Flavors and fine ingredients company Frutarom has agreed to buy Ireland’s Redbrook Ingredients Services for around $44.8 million. The purchase price also includes provision for an...

News

Philippe Saudan Chief Development Officer at Kuros

11.08.2016 - Kuros Biosciences has appointed Dr. Philippe Saudan as chief development officer and member of the executive board with immediate effect. With a PhD in biology
from the University...

News

Merck and Nanoco Sign Quantum Materials Deal

11.08.2016 - Germany chemicals and pharmaceuticals producer Merck KGaA and UK-based Nanoco Group, a specialist in developing and manufacturing cadmium-free quantum dots and other nanomaterials...

News

CIA Member Survey Reveals Positive UK Outlook

09.08.2016 - A survey of its members by the UK’s Chemical Industries Association (CIA) has shown that while some investment is expected to be hit by the uncertainty post-Brexit, three-quarters...

News

Pfizer Buys Gene Therapy Group Bamboo

08.08.2016 - Pfizer has acquired the remaining stake in Bamboo Therapeutics, a privately held gene therapy group based in Chapel Hill, North Carolina, USA, in a deal that could be worth as much...